The drug is still in the trial phase.
News-Medical.Net on MSN
Drug combination shows greater weight loss while preserving muscle mass
A recent research study found that a combination of the GLP-1 receptor agonist semaglutide and bimagrumab, an antibody that ...
Elaine Chen covers biotech, co-writes The Readout newsletter, and co-hosts STAT’s weekly biotech podcast, The Readout Loud. You can reach Elaine on Signal at elaineywchen.70. Veru said Monday that its ...
A gastroenterologist warns GLP-1 weight-loss drugs may cause hidden muscle loss. Experts explain risks and how to protect lean mass during rapid weight loss.
There's no question that glucagon-like peptide 1 (GLP-1) agonists represent a major advance in the treatment of obesity for patients with or without diabetes. In clinical trials, participants lost 15% ...
While GLP-1 drugs are effective for shedding pounds, there are concerns about potential risks and long-term effects.
Elaine Chen covers biotech, co-writes The Readout newsletter, and co-hosts STAT’s weekly biotech podcast, The Readout Loud. You can reach Elaine on Signal at elaineywchen.70. Scholar Rock said ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results